WHO ICTRP trial
Randomized, blinded, controlled design to evaluate the safety and tolerability…
ChiCTR2200055617 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200055617 |
|---|---|
| Public title | Randomized, blinded, controlled design to evaluate the safety and tolerability of recombinant herpes zoster vaccine in healthy people aged 50-70 years, and a phase I clinical study to initially explore immunogenicity |
| Scientific title | Randomized, blinded, controlled design to evaluate the safety and tolerability of recombinant herpes zoster vaccine in healthy people aged 50-70 years, and a phase I clinical study to initially explore immunogenicity |
| Primary sponsor | Hubei Provincial Center for Disease Control and Prevention |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Chickenpox - disease caused by herpes zoster virus infection |
| Interventions | Low-dose experimental group:Inject 1 dose into the deltoid muscle of the upper arm according to the 0 and 1 month immunization schedule;High-dose experimental group:Inject 1 dose into the deltoid muscle of the upper arm according to the 0… |
| Registration date | Jan 14, 2022 |
| Target size | Low-dose experimental group:20;High-dose experimental group:20;Placebo… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: